-
公开(公告)号：US11193116B2
公开(公告)日：2021-12-07
申请号：US15619196
申请日：2017-06-09
Applicant: Bioverativ Therapeutics Inc.
Inventor： Glenn Pierce , Samantha Truex , Robert T. Peters , Haiyan Jiang , Mark Brader
IPC: A61K38/36 , C12N9/64 , C07K14/745 , C07K16/36 , A61K38/00
Abstract: The present invention provides methods of administering long-acting Factor IX; methods of administering long-acting, chimeric and hybrid polypeptides comprising Factor IX; and methods of producing such chimeric and hybrid polypeptides using cells.
-
公开(公告)号：US10561714B2
公开(公告)日：2020-02-18
申请号：US15890284
申请日：2018-02-06
Applicant: Bioverativ Therapeutics Inc.
Inventor： Glenn Pierce , Samantha Truex , Robert T. Peters , Haiyan Jiang
IPC: A61K38/36 , A61K38/48 , A61K47/64 , A61K39/395 , C12N9/96 , A61K38/38 , C07K16/18 , C12N9/64 , C07K14/76 , A61K9/00 , A61P7/04
Abstract: The present invention provides methods of administering Factor IX; methods of administering chimeric and hybrid polypeptides comprising Factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.
-
公开(公告)号：US10568943B2
公开(公告)日：2020-02-25
申请号：US16271686
申请日：2019-02-08
Applicant: BIOVERATIV THERAPEUTICS INC.
Inventor： Glenn Pierce , Samantha Truex , Robert T. Peters , Haiyan Jiang
IPC: A61K38/36 , A61K38/48 , A61K47/64 , A61K39/395 , C12N9/96 , A61K38/38 , C07K16/18 , C12N9/64 , C07K14/76 , A61K9/00 , A61P7/04
Abstract: The present invention provides methods of administering Factor IX; methods of administering chimeric and hybrid polypeptides comprising Factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.
-
公开(公告)号：US09867873B2
公开(公告)日：2018-01-16
申请号：US14982934
申请日：2015-12-29
Applicant: Bioverativ Therapeutics Inc.
Inventor： Glenn Pierce , Samantha Truex , Robert T. Peters , Haiyan Jiang
IPC: C07K14/755 , A61K38/48 , A61K39/395 , C12N9/96 , A61K38/38 , C07K16/18 , C12N9/64 , C07K14/76 , A61K9/00 , A61K47/48
CPC classification number: A61K38/4846 , A61K9/0019 , A61K38/38 , A61K39/395 , A61K39/39533 , A61K39/3955 , A61K47/643 , C07K14/76 , C07K16/18 , C07K2317/21 , C07K2317/90 , C07K2317/94 , C07K2319/30 , C07K2319/31 , C07K2319/33 , C12N9/644 , C12N9/96 , C12Y304/21022
Abstract: The present invention provides methods of administering Factor IX; methods of administering chimeric and hybrid polypeptides comprising Factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.
-
公开(公告)号：US09675676B2
公开(公告)日：2017-06-13
申请号：US15043445
申请日：2016-02-12
Applicant: Bioverativ Therapeutics Inc.
Inventor： Glenn Pierce , Samantha Truex , Robert T. Peters , Haiyan Jiang
IPC: A61K38/38 , A61K38/48 , A61K39/395 , C12N9/96 , C07K16/18 , C12N9/64 , C07K14/76 , A61K9/00 , A61K47/48
CPC classification number: A61K38/4846 , A61K9/0019 , A61K38/38 , A61K39/395 , A61K39/39533 , A61K39/3955 , A61K47/643 , C07K14/76 , C07K16/18 , C07K2317/21 , C07K2317/90 , C07K2317/94 , C07K2319/30 , C07K2319/31 , C07K2319/33 , C12N9/644 , C12N9/96 , C12Y304/21022
Abstract: The present invention provides methods of administering Factor IX; methods of administering chimeric and hybrid polypeptides comprising Factor IX; chimeric and hybrid polypeptides comprising Factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.
-
Patent Agency Ranking
公开(公告)号：US10548954B2
公开(公告)日：2020-02-04
申请号：US16271689
申请日：2019-02-08
Applicant: BIOVERATIV THERAPEUTICS INC.
Inventor： Glenn Pierce , Samantha Truex , Robert T. Peters , Haiyan Jiang
IPC: A61K38/36 , A61K38/48 , A61K47/64 , A61K39/395 , C12N9/96 , A61K38/38 , C07K16/18 , C12N9/64 , C07K14/76 , A61K9/00 , A61P7/04
Abstract: The present invention provides methods of administering Factor IX; methods of administering chimeric and hybrid polypeptides comprising Factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.
-
公开(公告)号：US20190192640A1
公开(公告)日：2019-06-27
申请号：US16271686
申请日：2019-02-08
Applicant: BIOVERATIV THERAPEUTICS INC.
Inventor： Glenn Pierce , Samantha Truex , Robert T. Peters , Haiyan Jiang
IPC: A61K38/48 , A61K47/64 , C12N9/96 , C12N9/64 , C07K16/18 , A61K39/395 , A61K38/38 , C07K14/76 , A61K9/00
Abstract: The present invention provides methods of administering Factor IX; methods of administering chimeric and hybrid polypeptides comprising Factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.
-
公开(公告)号：US11225650B2
公开(公告)日：2022-01-18
申请号：US15619196
申请日：2017-06-09
Applicant: Bioverativ Therapeutics Inc.
Inventor： Glenn Pierce , Samantha Truex , Robert T. Peters , Haiyan Jiang , Mark Brader
IPC: A61K38/36 , C12N9/64 , C07K14/745 , C07K16/36 , A61K38/00
Abstract: The present invention provides methods of administering long-acting Factor IX; methods of administering long-acting, chimeric and hybrid polypeptides comprising Factor IX; and methods of producing such chimeric and hybrid polypeptides using cells.
-
公开(公告)号：US10898554B1
公开(公告)日：2021-01-26
申请号：US17032354
申请日：2020-09-25
Applicant: BIOVERATIV THERAPEUTICS INC.
Inventor： Glenn Pierce , Samantha Truex , Robert T. Peters , Haiyan Jiang
IPC: A61K38/36 , A61K38/48 , A61P7/04 , A61K47/64 , A61K38/38 , A61K39/395 , C07K16/18 , C12N9/64 , C07K14/76 , A61K9/00 , C12N9/96
Abstract: The present invention provides methods of administering Factor IX; methods of administering chimeric and hybrid polypeptides comprising Factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.
-
公开(公告)号：US20190192641A1
公开(公告)日：2019-06-27
申请号：US16271689
申请日：2019-02-08
Applicant: BIOVERATIV THERAPEUTICS INC.
Inventor： Glenn Pierce , Samantha Truex , Robert T. Peters , Haiyan Jiang
Abstract: The present invention provides methods of administering Factor IX; methods of administering chimeric and hybrid polypeptides comprising Factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.
-
-
-
-
-
-
-
-
-
Search Results
13
records
(took 0.026 seconds)
